SOMETHING’S GOTTA GIVECould This Non-Profit Drugmaker Solve U.S. Insulin Crisis?It’s planning to produce the diabetes drug at no more than $30 for a month’s supply—a fraction of some private pharma companies.Jing Luo, The ConversationMAY 09, 2022